• kids computing
  • mother1 daughter
  • kids food
  • kids leaning
  • girls
  • kids eating
  • kids side
  • kids run

2017 Initiatives, Projects and Collaborations

Continuing Professional Development / Meetings

  • ASCIA 2017 Conference 13-15 September - Auckland NZ www.ascia2017.com.au 
  • National Allergy Strategy infant feeding and allergy prevention implementation meeting (17 March 2017)
  • ASCIA SCIg (subcutaneous immunoglobulin) resources workshop (19 May 2017)
  • ASCIA TAPID (transplantation and primary immunodeficiency) project monthly teleconferences and face to face meeting (20-21 May 2017)
  • ASCIA WA immunology day (10 June 2017)
  • ASCIA advanced training meeting - environmental allergy (29 July 2017)

Website / Communications

Food Allergy / Anaphylaxis 
 

Respiratory / Insect Allergy 

Drug (Medication) Allergy 

  • New ASCIA drug allergy (cephalosporin) consensus statement for clinical immunology/allergy specialists (in final stage of review)
  • New ASCIA penicillin allergy e-training module for health professionals (in final stage of review)
  • National Allergy Strategy drug (medication) allergy scoping project (completed)

Skin Allergy 

  • Updated ASCIA information for patients, consumers and  carers on Hives (Urticaria) and Angioedema  (in final stage of review)
  • Updated ASCIA chronic spontaneous urticaria (CSU) Guidelines (under review)
  • New AIFA / ASCIA public awareness campaign on hives www.allergyimmunology.org.au/support-aifa/worldallergyweek

Primary Immunodeficiency (PID) / Autoimmunity 

  • New ASCIA PID clinical update for health professionals www.allergy.org.au/health-professionals/papers/pid
  • Revised ASCIA HAE position paper www.allergy.org.au/health-professionals/papers/hereditary-angioedema
  • New ASCIA immunodeficiency resources webpage (in final stage of development)
  • New and updated SCIg resources (in final stage of review)
  • ASCIA SCIg workshop (19 May 2017)
  • ASCIA TAPID (transplantation and primary immunodeficiency) project monthly teleconferences and face to face meeting (20-21 May 2017)
  • New ASCIA TAPID project publication (in development)
  • New ASCIA immunodeficiency register (in final stage of development)
  • New ASCIA PID newborn screening position statement (in development)
  • New and updated ASCIA information on autoimmunity (in final stage of review)

Research

 
Webpage updated June 2017

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.